Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HIV/AIDS
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: To identify infectious and non-infectious complications of HIV di...
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune suppression, viral resistance, end-organ disease, and mortality. To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults with perinatal HIV. To define the impact of perinatal HIV infection and ART on long-term mental and behavioral health outcomes.
Tracking Information
- NCT #
- NCT03279185
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute on Drug Abuse (NIDA)
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH Office of AIDS Research (OAR)
- National Institute of Mental Health (NIMH)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Investigators
- Principal Investigator: George R Seage, ScD, MPH Harvard School of Public Health Study Chair: Katherine Tassiopoulos, DSc, MPH Harvard School of Public Health Study Chair: Russell B Van Dyke, MD Tulane University School of Medicine